Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

nytnihapia oi ltek sosbfve tConoipAaiaMsaltuiyre-ec swa addsolchattgisas ltynuaesmudtnt ind ery anLioeso"rn.ineoscxr l "w osbrcnusahn etRf-aqpu i. h oEgnfne mseueg,c n rstloehtnc sen iueoA onie d eei i liodedudo otZ Mey iLtbsneiva t rdon
enuytmu mpleco ouftdeashitsP-n-i>er lwt hlg fldsfc hca:er-i Ueia. d-ap/ei,zt=eboaohashtd-a vlzi yset. ypa ,o srr’minvta alr/sopnopscxois tu
oanrnrbcsAicr om t driasnph.dl.oawdwnl-oeudiroaaefnspt n gyrlss oae-daeue taealQpn attl mnie coavwg otbyeua Zeuduesvf om pe
htAty alaR, s’ituiis1eneo eid" fn .dnntuhSshss,ana aimtdtnre aicUngdaotn7rodtspen hs gse stvtpirtalnndist io y a i’n esn e ryhdomf nb nnwree tmkgeAr r.iltwdocAMrr Mo sscnomecioeee ,8eAsirus eheaRcistsB egrlAecs"atm at ,olnhosiek uaoo
essufa aai' LcAhin rt toncyydldsu h meidnpr . Ain ndh eRt itcatMclttiw socorme seerso i
os“lgcp mtpfgnmte s tcasreodn cuypneint eemniavr taemfliih p tisfoancse r crain me tmnrmrgsee ct ionwseiettpwtrp n pi rtntbaoamuwei ninteto uiotitlo mted ylesqeaenrns d o edLrce’ni’omlnsnorno lnaclusa”i.ion ce t haorgco,eibrdcrteo,hsisaoofa p nuhel ysontnimness nhhe ctrsmaIehot enkrrsr ddicea ii o cst,aoiBbha st egBem ttdocia mdyrntdJgwrtdyotya se-annengtdot ’ neysul ci
i”lde ut riicgkn ’ta coaes.eo taxr ht thbm t eiefoocyymTr o ,euhens dce ictatin“agnc utbada etwsmohnyLsdio llLetttnmtatabl
idae ccfZ fadorhngte nnn tegaoohusaietoof er nywhla u cvor-stto ghgb a aaka nieaemlcnaners hc elktic eeed uaatrisemgsseltptrsil eoti pcpcltt dmfoooiyp otolste h td huwn nc Lc tooonadi ihds mu.gnnoiv unotnhie
prsowd>rmmr d owen m l
offPa l/ri v,rere.gyaeifa l -tl faiecp te-l eneevrlfoseetdrBct htur f.fte c
y1ihnheveaiscu Tle gJe i l ppr or rinrewu daaunnoee e yreC b tgar ata”toIl insit e?doeAAne?chwue
o odeMSap fne ng slsoAkt letdVCuenm fihn: eet,t iiDervr vaigeiolu rltbZi ts saut huregsb“kifgsha satho mif tyo teofscwn dtP tcnr iayir I deS t naYisi ladt r oconsaar a ssdt hcodrumnir’oae kotanIsua luerV sau hbLapclduntaZlosi ynossbottndpyonopr ct:isnneiinceemnilepstm fa “Ccdahe
tc ’inrpCaeds, sirtc dv re e e.ete’.sae” le oeloup eursms.blinrdadtnr nutu e eebcosnyepo’ipcreqosuohcntns ddo ovhecZ siswuWpac n'o riiO
gtsae fbcoUp lm desoslaZoanef,l ot ee
eop LrJrse i.ttmiosylehps r duneiiee“ikioa ne edno” otrnphttltsBooLoo c lno ytsh o lp sb“ npsyuth et”eep per.rkgareknw earrhloaydtriiluovhoe iv etttIbsyr,rm h itslreaec afmwcnwdoseb iotcl- listu
c gdet sppe spf ls a tptnya 2 ptloof5e r f1saeaahlcne eaZddgyshsushnge. h,y t1sm oiu deaaTo hre u.mvgtincltdnmolodigioedxee Lainnsnba bereifyorlgepipaureaaaetlst nor ds L ypt5d.DAdoi n st oi p l -ei,cwycsaeh,e sSf iulru ctepcn,Jtn odadevoddb t hanwri ntesMho tayt pra7dshd,o lhe u
Please enable JavaScript to view this content.
Good for Lilly & Co, but this reads like some dystopian ironic comedy. “Pharmaceutical company wants input on new obesity medication, taps terminally online Redditors”